JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
UDEC
6051
Innovator US Equity Ultra Buffer ETF December
UDEC
$244M
| $16.2K | ﹤0.01% |
463
| – | – |
2024 Q1
3 quarters
|
|
|
TDAY
6052
CALL
USA Today Co
TDAY
$1.04B
| $16.2K | ﹤0.01% |
3,200
| – | – |
2024 Q3
1 quarter
|
|
6053
PUT
Avis
CAR
$3.75B
| $16.1K | ﹤0.01% |
200
| – | – |
2023 Q3
5 quarters
|
|
|
NESRW
6054
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
6055
PUT
Celsius Holdings
CELH
$6.94B
| $15.8K | ﹤0.01% |
600
-463,600
| -100% | -$13.8M |
2024 Q1
3 quarters
|
|
6056
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$397M
| $15.8K | ﹤0.01% |
229
| – | – |
2022 Q4
8 quarters
|
|
6057
PUT
CRISPR Therapeutics
CRSP
$5.36B
| $15.7K | ﹤0.01% |
400
| – | – |
2024 Q1
3 quarters
|
|
|
CMPS
6058
Compass Pathways
CMPS
$1.65B
| $15.7K | ﹤0.01% |
4,162
+4,090
| +5,681% | +$20.7K |
2021 Q2
14 quarters
|
|
|
SRG
6059
CALL
Seritage Growth Properties
SRG
$95.8M
| $15.7K | ﹤0.01% |
3,800
| – | – |
2024 Q1
3 quarters
|
|
6060
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$119M
| $15.6K | ﹤0.01% |
315
+155
| +97% | +$8.07K |
2024 Q3
1 quarter
|
|
|
SBDS
6061
DELISTED
Solo Brands Inc
SBDS
| $15.6K | ﹤0.01% |
341
-51,796
| -99% | -$2.57M |
2021 Q4
12 quarters
|
|
|
CMRX
6062
DELISTED
Chimerix, Inc.
CMRX
| $15.5K | ﹤0.01% |
4,440
+2,901
| +188% | +$4.09K |
2013 Q2
46 quarters
|
|
6063
iShares Large Cap Moderate Quarterly Laddered ETF
IVVM
$183M
| $15.4K | ﹤0.01% |
+502
| New | +$15.5K |
2024 Q4
0 quarters
|
|
|
ARIS
6064
Aris Mining
ARIS
$3.58B
| $15.4K | ﹤0.01% |
4,391
-186,883
| -98% | -$779K |
2023 Q4
4 quarters
|
|
6065
Invesco S&P SmallCap Consumer Discretionary ETF
PSCD
$22.7M
| $15.1K | ﹤0.01% |
139
| – | – |
2024 Q2
2 quarters
|
|
6066
iShares MSCI Agriculture Producers ETF
VEGI
$162M
| $15.1K | ﹤0.01% |
426
+42
| +11% | +$1.56K |
2022 Q4
8 quarters
|
|
6067
PUT
Azenta
AZTA
$1.51B
| $15K | ﹤0.01% |
300
-900
| -75% | -$41K |
2024 Q1
3 quarters
|
|
|
KDKRW
6068
Kodiak AI Warrants
KDKRW
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
6069
Touchstone Securitized Income ETF
TSEC
$168M
| $14.8K | ﹤0.01% |
+569
| New | +$14.9K |
2024 Q4
0 quarters
|
|
6070
Owlet
OWLT
$147M
| $14.8K | ﹤0.01% |
3,319
+8
| +0.2% | +$38 |
2021 Q3
13 quarters
|
|
6071
Invesco Dorsey Wright Energy Momentum ETF
PXI
$56.5M
| $14.7K | ﹤0.01% |
331
-285
| -46% | -$13.2K |
2024 Q3
1 quarter
|
|
6072
Franklin US Mid Cap Multifactor Index ETF
FLQM
$1.44B
| $14.4K | ﹤0.01% |
266
| – | – |
2024 Q1
3 quarters
|
|
6073
VanEck Short High Yield Muni ETF
SHYD
$461M
| $14.2K | ﹤0.01% |
631
+132
| +26% | +$2.99K |
2023 Q3
5 quarters
|
|
6074
Outlook Therapeutics
OTLK
$140M
| $14.2K | ﹤0.01% |
7,489
+343
| +5% | +$1.41K |
2021 Q2
14 quarters
|
|
|
GATEW
6075
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
| – | – |
0
| – | – |
2023 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.